Advanced search
Publication Cover
Redox Report
Communications in Free Radical Research
Volume 7, 2002 - Issue 3
Submit an article Journal homepage
132
Views
9
CrossRef citations to date
0
Altmetric
Research Articles

Similarity in the distribution of F2-isoprostanes in the lipid subfractions of atherosclerotic plaque and in vitro oxidised low density lipoprotein

E. I. WaddingtonDepartment of Medicine University of Western Australia , Royal Perth Hospital and Western Australian Institute for Medical Research, Perth, Western Australia, Australia
,
I. B. PuddeyDepartment of Medicine University of Western Australia , Royal Perth Hospital and Western Australian Institute for Medical Research, Perth, Western Australia, Australia
,
T. A. MoriDepartment of Medicine University of Western Australia , Royal Perth Hospital and Western Australian Institute for Medical Research, Perth, Western Australia, Australia
&
K. D. CroftDepartment of Medicine University of Western Australia , Royal Perth Hospital and Western Australian Institute for Medical Research, Perth, Western Australia, Australia
Pages 179-184 | Published online: 19 Jul 2013

  • Morrow JD, Harris TM, Roberts U. Non-cyclooxygenase oxidative formation of a series of novel prostaglandins. Analytical ramifications for measurement of eicosanoids. Anal Biochem 1990; 184: 1–10.
  • Meagher EA, FitzGerald GA. Indices of lipid peroxidation in vivo: strengths and limitations. Free Radic Biol Med 2000; 28: 1745–1750.
  • Roberts U, Morrow JD. Measurement of F2-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med 2000; 2: 505-513.
  • Berger TM, Polidori MC, Dabbagh A et al. Antioxidant activity of vitamin C in iron-overloaded human plasma. J Biol Chem 1997; 272: 15656–15660.
  • Wiseman H, O'Reilly JD, Adlercreutz H et al. Isoflavone phytoestrogens consumed in soy decrease F2-isoprostane concentrations and increase resistance of low density lipoprotein to oxidation in humans. Am J Clin Nutr 2000; 72: 395–400.
  • Meagher EA, Barry OP, Lawson JA, Rokach J, FitzGerald GA. Effects of vitamin E on lipid peroxidation in healthy persons. JAMA 2001;285: 1178–1182.
  • Levine M, Wang Y, Padayatty SJ, Morrow J. A new recommended dietary allowance of vitamin C for healthy young women. Proc Natl Acad Sci USA 2001; 98: 9842–9846.
  • Haberland ME, Fogelman AM. The role of altered lipoproteins in the pathogenesis of atherosclerosis. Am Heart J1987; 113: 395-400.
  • Steinberg D. Oxidative modification of LDL and atherogenesis. Circulation 1997; 95: 1062–1071.
  • Berliner JA, Heinecke JW. The role of oxidised lipoproteins in atherogenesis. Free Radic Biol Med 1996; 20: 707–727.
  • Witzum JL, Steinberg D. Role of oxidised low density lipoprotein in atherogenesis. J Clin Invest 1991; 88: 1785–1792.
  • Esterbauer H, Gebicki J, Puhl H, Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med 1992; 13: 341–390.
  • Gniwotta C, Morrow JD, Roberts LJ, Kahn H. Prostaglandin F2- like compounds, F2-isoprostanes are present in increased amounts in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol 1997; 17:3236–3241.
  • Pratico D, Iuliano L, Mauriello A et al. Localisation of distinct F2-isoprostanes in human atherosclerotic lesions. J Clin Invest 1997; 100: 2028–2034.
  • Esterbauer H, Dieber-Rotheneder M, Waeg G, Striegl G, Jurgens G. Biochemical, structural, and functional properties of oxidized low-density lipoprotein. Chem Res Toxicol 1990; 3: 77–92.
  • Mallat Z, Nakamura T, Ohan J et al. The relationship of hydroxyeicosatetraenoic acids and F2-isoprostanes to plaque instability in human carotid atherosclerosis. J Clin Invest 1999; 103: 421–427.
  • Mori TA, Croft KD, Puddey IB, Beilin U. An improved method for the measurement of urinary and plasma F2-isoprostanes using gas chromatography-mass spectrometry. Anal Biochem 1999; 268: 117–125.
  • Croft KD, Proudfoot J, Moulton C, Beilin U. The effect of lipoproteins on the release of some eicosanoids by stimulated leukocytes: a possible role in atherogenesis. Eicosanoids 1991; 4: 75–81.
  • Markwell MAK, Haas SM, Bieber LL, Tolbert NE. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem 1978; 87: 206–210.
  • Croft KD, Puddey 1B, Rakic V, Abu-Amsha R, Dimmitt SB, Beilin U. Oxidative susceptibility of low density lipoproteins - influence of regular alcohol use. Alcohol Clin Exp Res 1996; 20: 980–984.
  • Croft KD, Dimmitt SB, Moulton C, Beilin U. Low density lipoprotein composition and oxidizability in coronary disease - apparent favourable effects of beta blockers. Atherosclerosis 1992; 97: 123–130.
  • Gopaul NK, Nourooz-Zadeh J, Mallet Al, Anggärd EE. Formation of PGF2-isoprostanes during the oxidative modification of low density lipoprotein. Biochem Biophys Res Commun 1994; 200: 338–343.
  • Lynch SM, Morrow JD, Roberts U, Frei B. Formation of non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in plasma and low density lipoprotein exposed to oxidative stress in vitro. J Clin Invest 1994; 93: 998-1004.
  • Moore KP, Darley-Usmar V, Morrow J, Roberts U. Formation of F2-isoprostanes during oxidation of human low-density lipoprotein and plasma by peroxynitrite. Circ Res 1997; 77: 335–341.
  • Morrow JD, Awad JA, Boss HJ, Blair IA, Roberts 2nd U. Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids. Proc Natl Acad Sci USA 1992; 89: 10721–10725.
  • Woolf N. Pathology of atherosclerosis. Br Med Bull 1990; 46: 960–985.
  • Bowry VW, Stocker R. Tocopherol-mediated peroxidation. The pro-oxidant effect of vitamin E on the radical-initiated oxidation of human low-density lipoprotein. J Am Chem Soc 1993; 115: 6029–6044.
  • Heydeck D, Upston JM, Viita H, Yld-Herttuala S, Stocker R. Oxidation of LDL by rabbit and human 15-lipoxygenase: prevalence of non-enzymatic reactions. J Lipid Res 2001; 42: 1082–1088.
  • Kühn H, Belkner J, Zaiss S, Fährenklemper T, Wholfeil S. Involvement of 15-lipoxygenase in early stages of atherogenesis. J Exp Med 1994; 179: 1903–1911.
  • Waddington E, Sienuarine K, Puddey I, Croft K. Identification and quantitation of unique fatty acid oxidation products in human atherosclerotic plaque using high-performance liquid chromatography. Anal Biochem 2001; 292: 234–244.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.